MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

MiniMed Group, Inc. Common StockNASDAQ: MMED

Net Margin · Q1 FY2026 · quarter ended Jul 2026

Net margin at 0.0%

Net margin was 0.0% in Q1 FY2026. On a trailing-twelve-month basis it was -10.2%. Over 3 fiscal years it narrowed by 6.4 pp.

Context

  • Net margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 11 analysts of 5.1% for the fiscal year ending Apr 2027, up from -10.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
0.0%+21.9 pp QoQ
Last fiscal yearApr 2026
-10.7%-1.5 pp YoY
LTMJul 2026
-10.2%— YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter—+7.7 pp—
1 year-1.5 pp+15.7 pp+17.2 pp
3 years-6.4 pp+21.3 pp+27.7 pp
5 years+26.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-10.7%
Year-over-year change
-1.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 net margin of -10.2% is the 5th highest of the 7 companies compared; the peer median is 1.5%.
  • Over three fiscal years its change of -6.4 pp compares with a peer median of +3.7 pp.
MMED Competitors Peer median
Net Margin for MMED and competitors
Company Period LTM level YoY 3-year change
DXCMDexCom, Inc.LTM Jun 202620.1% +6.8 pp+6.2 pp
MDTMedtronic plcLTM Jul 202613.9% +0.3 pp+1.2 pp
PODDInsulet CorporationLTM Jun 202612.3% +2.3 pp+8.8 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-9.2% +7.5 pp-8.4 pp
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026-10.2% —-6.4 pp
BBNXBeta Bionics, Inc.LTM Mar 2026-60.3% +41.4 pp+36100.7 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding MMED) 1.5%+7.2 pp+3.7 pp

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Revenue2.25B2.47B2.72B3.1B
Cost of Revenue937M1.03B1.19B1.42B
Gross Profit1.31B1.44B1.53B1.68B
Gross Margin58.3%58.2%56.2%54.2%
Research & Development429M437M438M448M
Selling, General & Admin960M1.06B1.13B1.18B
Operating Expenses1.38B1.51B1.73B1.63B
Depreciation & Amortization115M129M143M156M
EBITDA39M59M107M205M
EBITDA Margin1.7%2.4%3.9%6.6%
Operating Income(69M)(69M)(202M)49M
Operating Margin-3.1%-2.8%-7.4%1.6%
Interest Income0000
Interest Expense0000
Other Income / Expenses(7M)(1M)(1M)(236M)
Income Before Tax(76M)(70M)(203M)(187M)
Pre-Tax Margin-3.4%-2.8%-7.5%-6.0%
Income Tax Expense16M38M48M128M
Net Income(96M)(112M)(250M)(331M)
Net Margin-4.3%-4.5%-9.2%-10.7%
EPS (Basic)(0.34)(0.40)(0.89)(1.29)
EPS (Diluted)(0.34)(0.40)(0.89)(1.29)
Weighted Avg Shares280.81M280.81M280.81M256.6M
Weighted Avg Shares (Diluted)280.81M280.81M280.81M256.6M

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.